Towards this goal, we investigated the dynamics of spike-specific CD4+ and CD8+ T-cell responses elicited after two and three doses of COVID-19 vaccine in a cohort of 50 adult PLWH receiving antiretroviral therapy and 87 control participants without HIV. The gene discussed is CD4; the disease is COVID-19.